Efficacy and safety of voriconazole and CYP2C19 polymorphism for optimised dosage regimens in patients with invasive fungal infections | |
Wang, Taotao; Zhu, Huifang; Sun, Jinyao; Cheng, Xiaoliang; Xie, Jiao; Dong, Haiyan; Chen, Limei; Wang, Xue; Xing, Jianfeng; Dong, Yalin | |
刊名 | INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS |
2014 | |
卷号 | 44期号:[db:dc_citation_issue]页码:436-442 |
关键词 | Efficacy Hepatotoxicity Voriconazole CYP2C19 Safety Trough plasma concentrations |
ISSN号 | 0924-8579 |
DOI | [db:dc_identifier_doi] |
URL标识 | 查看原文 |
WOS记录号 | [DB:DC_IDENTIFIER_WOSID] |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/3302532 |
专题 | 西安交通大学 |
推荐引用方式 GB/T 7714 | Wang, Taotao,Zhu, Huifang,Sun, Jinyao,et al. Efficacy and safety of voriconazole and CYP2C19 polymorphism for optimised dosage regimens in patients with invasive fungal infections[J]. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS,2014,44([db:dc_citation_issue]):436-442. |
APA | Wang, Taotao.,Zhu, Huifang.,Sun, Jinyao.,Cheng, Xiaoliang.,Xie, Jiao.,...&Dong, Yalin.(2014).Efficacy and safety of voriconazole and CYP2C19 polymorphism for optimised dosage regimens in patients with invasive fungal infections.INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS,44([db:dc_citation_issue]),436-442. |
MLA | Wang, Taotao,et al."Efficacy and safety of voriconazole and CYP2C19 polymorphism for optimised dosage regimens in patients with invasive fungal infections".INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS 44.[db:dc_citation_issue](2014):436-442. |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论